BRPI0516172A - processo para a preparação de 4,5-diidro-pirazol[3,4-c]pirid-2-onas - Google Patents

processo para a preparação de 4,5-diidro-pirazol[3,4-c]pirid-2-onas

Info

Publication number
BRPI0516172A
BRPI0516172A BRPI0516172-0A BRPI0516172A BRPI0516172A BR PI0516172 A BRPI0516172 A BR PI0516172A BR PI0516172 A BRPI0516172 A BR PI0516172A BR PI0516172 A BRPI0516172 A BR PI0516172A
Authority
BR
Brazil
Prior art keywords
dihydro
pyrid
ones
preparation
pyrazolo
Prior art date
Application number
BRPI0516172-0A
Other languages
English (en)
Inventor
Boguslaw M Mudryk
Nicolas Cuniere
Dau-Ming Hsieh
Lucius T Rossano
Jing Liang
Huiping Zhang
Rulin Zhao
Bei Wang
Adrian David
Bang-Chi Chen
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of BRPI0516172A publication Critical patent/BRPI0516172A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCESSO PARA A PREPARAçãO DE 4,5-DIlDRO-PIRAZOL¢3,4-c!PIRID-2-ONAS. A presente invenção refere-se a um novo processo e intermediários do mesmo para a preparação de 4,5-diidro-pirazol¢3,4-c!pirid-2-onas do tipo mostrado abaixo a partir de hidrazinas de fenila apropriadas. Estes compostos podem ser úteis como inibidores de fator Xa.
BRPI0516172-0A 2004-09-28 2005-09-27 processo para a preparação de 4,5-diidro-pirazol[3,4-c]pirid-2-onas BRPI0516172A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61375404P 2004-09-28 2004-09-28
US63762304P 2004-12-20 2004-12-20
US11/235,647 US7304157B2 (en) 2004-09-28 2005-09-26 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
PCT/US2005/034511 WO2006036926A2 (en) 2004-09-28 2005-09-27 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Publications (1)

Publication Number Publication Date
BRPI0516172A true BRPI0516172A (pt) 2008-08-26

Family

ID=36100112

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516172-0A BRPI0516172A (pt) 2004-09-28 2005-09-27 processo para a preparação de 4,5-diidro-pirazol[3,4-c]pirid-2-onas

Country Status (11)

Country Link
US (3) US7304157B2 (pt)
EP (1) EP1805176A2 (pt)
JP (1) JP2008514710A (pt)
KR (1) KR20070067176A (pt)
AU (1) AU2005289598A1 (pt)
BR (1) BRPI0516172A (pt)
CA (1) CA2582222A1 (pt)
IL (1) IL182147A0 (pt)
MX (1) MX2007003427A (pt)
NO (1) NO20071634L (pt)
WO (1) WO2006036926A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI331526B (en) * 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
TW200303201A (en) * 2001-12-10 2003-09-01 Bristol Myers Squibb Co Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
ES2336439T3 (es) * 2002-01-21 2010-04-13 N.V. Organon Proceso para la preparacion de 7-alfa-metilesteroides.
US7388096B2 (en) * 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor
US20060069085A1 (en) * 2004-09-28 2006-03-30 Rulin Zhao Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
RU2007126770A (ru) * 2004-12-15 2009-01-27 Бристол-Маерс Сквибб Компани (Us) Кристаллические формы ингибитора фактора ха
FI20070471A0 (fi) * 2007-06-13 2007-06-13 Glykos Finland Oy Ravinnelisäkompositiota
EP3190111B1 (en) * 2014-09-02 2020-05-06 CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Pyrazolo[3,4-c]pyridine derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5423698A (en) * 1994-03-30 1995-06-13 Molex Incorporated Electrical connector system for a video display tube yoke
PL204263B1 (pl) 2001-09-21 2009-12-31 Bristol Myers Squibb Co Pochodna 1H-pirazolo[3,4-c]pirydyny i jej zastosowanie oraz kompozycja farmaceutyczna i jej zastosowanie
TWI331526B (en) 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
TW200303201A (en) * 2001-12-10 2003-09-01 Bristol Myers Squibb Co Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
US7388096B2 (en) 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor
US7396932B2 (en) * 2004-09-28 2008-07-08 Bristol-Myers Squibb Company Process for preparing 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US20060069260A1 (en) * 2004-09-28 2006-03-30 Huiping Zhang Preparation of N-aryl pyridones
US20060069085A1 (en) 2004-09-28 2006-03-30 Rulin Zhao Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Also Published As

Publication number Publication date
AU2005289598A1 (en) 2006-04-06
WO2006036926B1 (en) 2007-03-15
KR20070067176A (ko) 2007-06-27
US20060069119A1 (en) 2006-03-30
NO20071634L (no) 2007-06-21
EP1805176A2 (en) 2007-07-11
WO2006036926A3 (en) 2007-01-18
MX2007003427A (es) 2007-05-10
US20070282106A1 (en) 2007-12-06
US7579472B2 (en) 2009-08-25
IL182147A0 (en) 2007-07-24
WO2006036926A2 (en) 2006-04-06
US7304157B2 (en) 2007-12-04
CA2582222A1 (en) 2006-04-06
JP2008514710A (ja) 2008-05-08
US20080009626A1 (en) 2008-01-10
US7435821B2 (en) 2008-10-14

Similar Documents

Publication Publication Date Title
BRPI0516187A (pt) processo para preparação de [3, 4-c]pirid-2-onas de 4, 5-diidro-pirazolo
BRPI0516172A (pt) processo para a preparação de 4,5-diidro-pirazol[3,4-c]pirid-2-onas
BR0214845A (pt) Sìntese de 4,5-diidro-pirazol[3,4-c]pirid-2-onas
UA99896C2 (uk) Спосіб одержання глюкопіранозилзаміщених похідних бензилбензолу, проміжні продукти та способи їх одержання
NZ624460A (en) Process for making modulators of cystic fibrosis transmembrane conductance regulator
MY152283A (en) Polo-like kinase inhibitirs
WO2009146218A8 (en) Compounds including an anti-inflammatory pharmacore and methods of use
SG170729A1 (en) Processes and intermediates for preparing steric compounds
EA201100759A1 (ru) Арилоазол-2-илцианоэтиламиносоединения противопаразитарного действия, обогащенные одним из энантиомеров
ATE537136T1 (de) Neues verfahren zur herstellung von säurechloriden
CR11452A (es) 5-((3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino)-1h-quinolin-2-onas, un proceso para su produccion y su uso como agentes antiflamatorios
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200612959A (en) Method for preparing hydroxamic acids
BRPI0517390A (pt) processo para a preparação de derivados de [1,4,5]-oxadiazepina
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
CR9472A (es) Derivados de aminoacidos
BRPI0513807A (pt) sìntese de amidas do ácido 6, 7 - diidro - 5h - imidazo [1, 2-a] imidazol - 3 - sulfÈnico
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
DE602006005230D1 (de) Verfahren zur herstellung von 2-azabicycloä3.3.0üoctan-3-carbonsäurederivaten
TW200716555A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
BRPI0516932A (pt) processo para a preparação de compostos de purina
TW200716521A (en) Substituted aryl oximes

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]